Press release
Niraparib Market Report- Trends, Demand, Key Players, and Regional Data Statistics | Everest Pharmaceuticals Limited
The Niraparib Market research report also offers in-depth analysis supported by reliable statistics on revenue for the forecast period. Niraparib Market includes details like company description, total company revenue, significant business, and sales. Moreover, Niraparib Market report also highlights critical manufacturers and analyzes their product, profile, revenue, and developments.Download FREE PDF of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5480700
Niraparib market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Niraparib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- 100mg*30 Capsules
- 100mg*60 Capsules
- 100mg*90 Capsules
Segment by Application
- Recurrent Epithelial Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Cancer
- Other
By Company
- TESARO
- Everest Pharmaceuticals Limited
Get Discount on Purchase this Report @ https://www.reportsnreports.com/purchase.aspx?name=5480700
Table of Contents
1 Study Coverage
1.1 Niraparib Product Introduction
1.2 Market by Type
1.2.1 Global Niraparib Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100mg*30 Capsules
1.2.3 100mg*60 Capsules
1.2.4 100mg*90 Capsules
1.3 Market by Application
1.3.1 Global Niraparib Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Recurrent Epithelial Ovarian Cancer
1.3.3 Fallopian Tube Cancer
1.3.4 Primary Peritoneal Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Niraparib Sales Estimates and Forecasts 2017-2028
2.2 Global Niraparib Revenue Estimates and Forecasts 2017-2028
2.3 Global Niraparib Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Niraparib Sales by Region
2.4.1 Global Niraparib Sales by Region (2017-2022)
2.4.2 Global Sales Niraparib by Region (2023-2028)
2.5 Global Niraparib Revenue by Region
2.5.1 Global Niraparib Revenue by Region (2017-2022)
2.5.2 Global Niraparib Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Niraparib Sales by Manufacturers
3.1.1 Global Top Niraparib Manufacturers by Sales (2017-2022)
3.1.2 Global Niraparib Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Niraparib in 2021
3.2 Global Niraparib Revenue by Manufacturers
3.2.1 Global Niraparib Revenue by Manufacturers (2017-2022)
3.2.2 Global Niraparib Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Niraparib Revenue in 2021
3.3 Global Niraparib Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Niraparib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Niraparib Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Niraparib Sales by Type
4.1.1 Global Niraparib Historical Sales by Type (2017-2022)
4.1.2 Global Niraparib Forecasted Sales by Type (2023-2028)
4.1.3 Global Niraparib Sales Market Share by Type (2017-2028)
4.2 Global Niraparib Revenue by Type
4.2.1 Global Niraparib Historical Revenue by Type (2017-2022)
4.2.2 Global Niraparib Forecasted Revenue by Type (2023-2028)
4.2.3 Global Niraparib Revenue Market Share by Type (2017-2028)
4.3 Global Niraparib Price by Type
4.3.1 Global Niraparib Price by Type (2017-2022)
4.3.2 Global Niraparib Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Niraparib Sales by Application
5.1.1 Global Niraparib Historical Sales by Application (2017-2022)
5.1.2 Global Niraparib Forecasted Sales by Application (2023-2028)
5.1.3 Global Niraparib Sales Market Share by Application (2017-2028)
5.2 Global Niraparib Revenue by Application
5.2.1 Global Niraparib Historical Revenue by Application (2017-2022)
5.2.2 Global Niraparib Forecasted Revenue by Application (2023-2028)
5.2.3 Global Niraparib Revenue Market Share by Application (2017-2028)
5.3 Global Niraparib Price by Application
5.3.1 Global Niraparib Price by Application (2017-2022)
5.3.2 Global Niraparib Price Forecast by Application (2023-2028)
6 North America
6.1 North America Niraparib Market Size by Type
6.1.1 North America Niraparib Sales by Type (2017-2028)
6.1.2 North America Niraparib Revenue by Type (2017-2028)
6.2 North America Niraparib Market Size by Application
6.2.1 North America Niraparib Sales by Application (2017-2028)
6.2.2 North America Niraparib Revenue by Application (2017-2028)
6.3 North America Niraparib Market Size by Country
6.3.1 North America Niraparib Sales by Country (2017-2028)
6.3.2 North America Niraparib Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Niraparib Market Size by Type
7.1.1 Europe Niraparib Sales by Type (2017-2028)
7.1.2 Europe Niraparib Revenue by Type (2017-2028)
7.2 Europe Niraparib Market Size by Application
7.2.1 Europe Niraparib Sales by Application (2017-2028)
7.2.2 Europe Niraparib Revenue by Application (2017-2028)
7.3 Europe Niraparib Market Size by Country
7.3.1 Europe Niraparib Sales by Country (2017-2028)
7.3.2 Europe Niraparib Revenue by Country (2017-2028)
and more..
+ 1 888 391 5441
sales@reportsandreports.com
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Niraparib Market Report- Trends, Demand, Key Players, and Regional Data Statistics | Everest Pharmaceuticals Limited here
News-ID: 2574917 • Views: …
More Releases from ReportsnReports
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Niraparib
Castrate Resistant Prostrate Cancer Pipeline Insights, Treatment Drugs, Clinical …
DelveInsight's, "Castrate Resistant Prostrate Cancer Pipeline Insight, 2024," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Castrate Resistant Prostrate Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover the latest drugs and treatment options…
GSK's ZEJULA (niraparib) Market Size expected to increase by 2032, reports Delve …
The Latest report, ZEJULA Market Size, Forecast, and Drug Insight 2032 is published by DelveInsight, a leader in healthcare research firm, providing insights into the ZEJULA market landscape and market forecast of ZEJULA up to 2032. This report is now available for review and analysis.
Are you interested in finding out the projected market size of ZEJULA in 2032? Click @ ZEJULA Market Size - https://www.delveinsight.com/report-store/zejula-emerging-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=druginsightpr&utm_campaign=apr
The ZEJULA Market Report…
Ovarian Cancer Pipeline, Clinical Trials Studies, Agreements & Collaborations, a …
DelveInsight's, "Ovarian Cancer Pipeline Insight 2023" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Ovarian Cancer pipeline landscape. It covers the Ovarian Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Ovarian Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Ovarian Cancer…
Niraparib Market Forecast by 2025: QY Research
This recently published report examines the global Niraparib market for the projected period of 7-years, i.e. between 2018 and 2025. The report highlights the accomplishments and opportunities lies in the market throughout the forecasted period. The report offers the thorough information about the overview and the scope of the global Niraparib market along with its drivers, restraints, and trends. It also classifies the market into different segments such as by…
Poly Adenosine Diphosphate Ribose Polymerase Market Analysis And Growth Rate to …
Poly adenosine diphosphate ribose polymerase (PARP) is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain and transfer them to the target proteins. These proteins aid in restoring the damage in DNA caused due to various factors such as exposure to UV rays, radiation, some anti-cancer drugs or other substances in the environment. PARP inhibitors aid in blocking the enzyme important for the repair…
New Survey on Global PARP Inhibitor Market: Size, Trends and Forecasts (2016-202 …
Researchmoz added Most up-to-date research on "Global PARP Inhibitor Market: Size, Trends and Forecasts (2016-2020)" to its huge collection of research reports.
The report titled Global PARP Inhibitor Market: Size, Trends and Forecasts (2016-2020) provides an in-depth analysis of the global PARP inhibitor market with detailed analysis of market size on the basis of value along with the comprehensive examination of each of the segments of the market, namely, Lynparza, Niraparib,…
